title: Reply to "concern over your recent paper on risperidone long-acting injectable for treatment-resistant schizophrenia".
authors.affiliation: Division of Medical Treatment and Rehabilitation, Chiba University Center for Forensic Mental Health, Chiba, Japan. Electronic address: kanahara@faculty.chiba-u.jp.
authors.forename: Nobuhisa
authors.initials: N
authors.lastname: Kanahara
authors.affiliation: Department of Psychiatry and Psychotherapy, Ludwig Maximilian University of Munich, Munich, Germany; Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan.
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Kimura
authors.affiliation: Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan.
authors.forename: Masaomi
authors.initials: M
authors.lastname: Iyo
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D011618:Psychotic Disorders / Q000150:complications*; D018967:Risperidone / Q000008:administration & dosage*; D012559:Schizophrenia / Q000150:complications* / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D018967:Risperidone